Nasdaq Oprx News Today

OptimizeRx (NASDAQ:OPRX – Get Free Report) and ICTS International (OTCMKTS:ICTSF – Get Free Report) are both small-cap computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends and analyst recommendations. Earnings and Valuation This table compares […]

JMP Securities reissued their market outperform rating on shares of OptimizeRx (NASDAQ:OPRX – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $15.00 price target on the stock. A number of other brokerages also recently commented on OPRX. Royal Bank of Canada reissued an outperform rating and […]

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among analysts that […]

JMP Securities reissued their market outperform rating on shares of OptimizeRx (NASDAQ:OPRX – Free Report) in a research report released on Tuesday, Benzinga reports. JMP Securities currently has a $15.00 target price on the stock. Several other brokerages have also commented on OPRX. Stifel Nicolaus restated a buy rating and set a $13.00 target price […]

Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that […]

OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price objective among analysts […]

L2 Asset Management LLC purchased a new position in OptimizeRx Co. (NASDAQ:OPRX – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 12,170 shares of the company’s stock, valued at approximately $95,000. Other institutional investors and hedge funds also […]

Jacob Asset Management of New York LLC lifted its stake in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 30.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 370,330 shares of the company’s stock after purchasing an additional 85,720 shares during […]

Avenir Corp cut its holdings in OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 7.9% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 381,660 shares of the company’s stock after selling 32,913 shares during the quarter. OptimizeRx makes up 0.5% of Avenir Corp’s holdings, […]